How does advanced prostate cancer research translate into patient care?

With more than 25 years of being involved in research to detect and characterize prostate cancers at early stages, John Kurhanewicz, PhD, is using his work to impact patient care.

Kurhanewicz—a professor in residence and director of the University of California, San Francisco (UCSF) Body Research Interest Group, the Biomedical NMR Lab and the Kurhanewicz Laboratory—has focused on advancing MRI techniques to provide more accurate characterization of the extent and aggressiveness of prostate cancer in individual patients.

The UCSF Department of Radiology & Biomedical Imaging released a video in which Kurhanewicz discusses how his research translates into patient care. He discusses how his team improved the MRI exam for prostate cancer by adding new metabolic parameters, which light up when cancer is present.

Recently, the team has added parameters to the multiparametric prostate imaging exam which is now being performed in clinical practice.

Full details here:

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.